$BFLY

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Financial Officer - John Doherty Chairman and Chief Executive Officer - Joseph DeVivo TAKEAWAYS Revenue -- $32.6 million, an increase of 39% year over year driven primarily by the growth of the Butterfly Embedded segment. Embedded Revenue -- $10.8 million, representing 439% year-over-year growth due to development work and milestones from the Midjourney partnership.

Original reporting
Published Jul 31, 2026, 3:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 3:47 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Butterfly (BFLY) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$BFLYBullishMed
01

Why it matters

The most tradable elements are the raised Q3 and FY 2026 guidance ranges, the magnitude of gross margin expansion, and the stated schedule for key commercialization milestones (home care implementation, FedRAMP certification, and Apollo chip delivery).

02

Market read

Traders can update models immediately using the disclosed guidance ranges and operating metrics, especially the shift toward higher-margin Embedded licensing and the narrowing adjusted EBITDA loss.

03

What to watch

International revenue decline is attributed to timing and tough comparisons, which could indicate demand softness rather than purely calendar effects; also, VCOM and FedRAMP milestones are execution-dependent.

Relevance 8/10Novelty 7/10Timing: pre-market today, after-hours earnings call transcript published

Background

Butterfly Network held its Q2 2026 earnings call, emphasizing growth from its Embedded licensing segment and progress toward enterprise software and next-generation semiconductor plans.

Company-level read

Ticker impact

$BFLYBullishMedium confidence
Context

Butterfly reported Q2 2026 results and raised Q3 revenue guidance to $26M-$30M, plus FY 2026 revenue to $119M-$123M.

Expected impact

Likely positive bias for the next session and into Q3 as traders price the raised revenue and narrowing adjusted EBITDA loss, tempered by international weakness.

Evidence & confidence

The article discloses multiple forward-looking guidance updates (Q3 and FY) alongside operating improvements (gross margin expansion, smaller adjusted EBITDA loss). The main offset is a stated 14% international revenue decline tied to timing and comparisons.

Market effects

Reinforces investor focus on ultrasound device companies with licensing/embedded software models and enterprise adoption milestones.

Brazil regulatory authorization and a first U.S. state implementation point to incremental demand catalysts, while international timing issues remain a drag.

Midjourney partnership delivery timing (late 2027/early 2028) keeps longer-dated AI imaging optionality in view, but near-term results hinge on execution.

Counterpoint

Raised guidance may still be consistent with continued adjusted EBITDA losses, so the stock could re-rate down if embedded growth or home-care rollout slips.

Key entities

  • Butterfly Network

    Reported Q2 2026 revenue and margins, discussed Embedded/Midjourney partnership progress, and raised Q3 and FY 2026 guidance.

  • Joseph DeVivo

    CEO who discussed imaging performance claims for the P5.1 chip and reiterated Apollo chip delivery timing to Midjourney.

  • John Doherty

    CFO who provided financial results, guidance ranges, and commentary on cash usage and risk factors.

Related articles

$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.

$BFLYMedAI 9/10

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Butterfly Network (BFLY) reported Q2 2026 revenue of $32.6M, up 39% y/y, driven by Embedded revenue of $10.8M (+439%). Gross profit rose to $23.3M and gross margin to 71%. Adjusted EBITDA loss narrowed to $1.4M. Q3 revenue guidance is $26M to $30M, and FY2026 revenue guidance is $119M to $123M.

$BFLYMedAI 8/10

Butterfly Network, Inc. Q2 2026 Earnings Call Summary

Butterfly Network, Inc. reported Q2 2026 progress driven by POCUS, Home and Community Care, and Embedded partnerships. Embedded revenue rose 439% on the Midjourney partnership. Gross margin was 71%. Full-year 2026 revenue guidance was raised to $119 million-$123 million. Home and Community Care first commercial implementation starts Oct 1, with revenue in Q4 2026.

$BFLYHighAI 9/10

Butterfly Network, Inc. (BFLY): Results of Operations and Financial Condition

Butterfly Network, Inc. (BFLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bfly-20260730xexx991.htm EX-99.1 Document Exhibit 99.1 Butterfly Network Reports Second Quarter 2026 Financial Results Delivered Record Revenue and Adjusted EBITDA Loss Above Guidance • Raised full year Revenue and Improved Adjusted EBITDA Guidance • Delivered quarterly

$BFLYMed

Butterfly Network Stock Soars 56% on Midjourney Deal: Buy or Sell in 2026?

Butterfly Network shares rose 55.87% to $8.90 on June 18 after AI startup Midjourney said it built a full-body ultrasound scanner using 40 Butterfly Ultrasound-on-Chip modules. The companies’ licensing/co-development deal could bring Butterfly up to $74M in expected payments, and Butterfly reported Q1 revenue of $26.5M (+25%) and gross margin of 68.9%, while maintaining 2026 revenue guidance of $117M–$121M.